Publications by authors named "Maureen Andrew"

Claim this Profile
F
Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
Brian W McCrindle, Cedric Manlhiot, Andrew Cochrane, Robin Roberts, Marina Hughes, Maureen Andrew

J Am Coll Cardiol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
Paul Monagle, Andrew Cochrane, Robin Roberts, Cedric Manlhiot, Robert Weintraub, Maureen Andrew

J Am Coll Cardiol· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of age on in vitro plasmin generation in the presence of fibrin monomer.
Nagina Parmar, Lesley G Mitchell, Leslie R Berry, Maureen Andrew, Anthony K C Chan

Acta Haematol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urgent clinical challenges in children with ischemic stroke: analysis of 1065 patients from the 1-800-NOCLOTS pediatric stroke telephone consultation service.
Stefan Kuhle, Lesley Mitchell, Maureen Andrew, Anthony K Chan, Patricia Massicotte

Stroke· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study evaluating post-thrombotic syndrome in children.
Stefan Kuhle, Barbara Koloshuk, Velma Marzinotto, Mary Bauman, Patricia Massicotte, Maureen Andrew

Thromb Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired fibrinolytic activity is present in children with dyslipidemias.
Manuela Albisetti, Anthony K C Chan, Brian W McCrindle, Derek Wong, Paul Monagle, Maureen Andrew

Pediatr Res· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study.
Lesley Mitchell, Maureen Andrew, Kim Hanna, Thomas Abshire, Jacqueline Halton

Thromb Haemost· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central venous line-related thrombosis in children: association with central venous line location and insertion technique.
Christoph Male, Peter Chait, Maureen Andrew, Kim Hanna, Jim Julian

Blood· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolytic system in adolescents: response to venous occlusion stress tests.
Paul Monagle, Anthony K C Chan, Manuela Albisetti, Patricia Vegh, Maureen Andrew

Pediatr Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of covalent serpin-heparinoid complexes on plasma thrombin generation on fetal distal lung epithelium.
Leslie R Berry, Petr Klement, Maureen Andrew, Anthony K C Chan

Am J Respir Cell Mol Biol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease.
Manuela Albisetti, Anthony K C Chan, Brian W McCrindle, Derek Wong, Patricia Vegh, Maureen Andrew

Blood Coagul Fibrinolysis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Lesley G Mitchell, Maureen Andrew, Kim Hanna, Thomas Abshire, Jacqueline Halton

Cancer· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.
Patricia Massicotte, Jim A Julian, Michael Gent, Karen Shields, Velma Marzinotto, Maureen Andrew

Thromb Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-finding and pharmacokinetic profiles of prophylactic doses of a low molecular weight heparin (reviparin-sodium) in pediatric patients.
Patricia Massicotte, Jim A Julian, Velma Marzinotto, Michael Gent, Karen Shields, Maureen Andrew

Thromb Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.
Patricia Massicotte, Jim A Julian, Michael Gent, Karen Shields, Velma Marzinotto, Maureen Andrew

Thromb Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective treatment of ligneous conjunctivitis with topical plasminogen.
Patrick Watts, Palanisamy Suresh, Eedy Mezer, Anna Ells, Manuela Albisetti, Maureen Andrew

Am J Ophthalmol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.
Christoph Male, Peter Chait, Jeffrey S Ginsberg, Kim Hanna, Maureen Andrew

Thromb Haemost· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
Anthony K C Chan, Leslie R Berry, Paul T Monagle, Maureen Andrew

Thromb Haemost· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low molecular weight heparin in children.
Manuela Albisetti, Maureen Andrew

Eur J Pediatr· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis